Selective Variceal Decompression: Current Status
Author Information
Author(s): Gongliang Jin, Layton F. Rikkers
Primary Institution: University of Nebraska Medical Center
Conclusion
The distal splenorenal shunt (DSRS) is effective in managing variceal hemorrhage but does not improve long-term survival compared to nonselective shunts.
Supporting Evidence
- The DSRS has been widely accepted for treating variceal hemorrhage, with over 2,700 cases reported since 1984.
- Patients with non-alcoholic cirrhosis showed longer survival rates compared to those with alcoholic cirrhosis.
- Controlled trials have shown a lower frequency of encephalopathy after DSRS compared to nonselective shunts.
Takeaway
Doctors use a special surgery called the distal splenorenal shunt to help people with bleeding problems in their stomach, but it doesn't help them live longer than other methods.
Methodology
The study reviewed various non-randomized and randomized trials comparing the DSRS to other treatments for variceal hemorrhage.
Limitations
The study primarily included patients with alcoholic cirrhosis, which may not represent all patient populations.
Participant Demographics
The majority of patients had non-alcoholic cirrhosis or noncirrhotic portal hypertension, with 44% classified as Child's A, 42% as Child's B, and 14% as Child's C.
Want to read the original?
Access the complete publication on the publisher's website